Thus, other potential mechanism(s) such as activating mutation, miRNA regulation or regulation through other interacting molecules could be involved behind the elevated expression of MDA-9/Syntenin in the progressive stages of HNSCC. The gene discussed is SDCBP; the disease is head and neck squamous cell carcinoma.